Product Information
APRODINE TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0720 per EA under NDC 00904730224. Its NADAC has been published 167 times since Apr 19, 2023.
Strength
60; 2.5 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904730224
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
11/11/2022
Pharmacological Classes
Price Statistics
The NADAC for APRODINE TABLET has been published 167 times since Apr 19, 2023, and over the history we have for it it has risen 53.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0720 per EA |
|---|---|
| All-time high | $0.0720 (Jun 24, 2026) |
| All-time low | $0.0420 (Oct 23, 2024) |
| 52-week high | $0.0720 |
| 52-week low | $0.0454 |
| Median price | $0.0470 |
| Average price | $0.0482 |
| Largest weekly change | +17.1% (Mar 18, 2026) |
| Weeks tracked | 167 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APRODINE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for APRODINE TABLET, manufactured by Major Pharmaceuticals, is $0.0720 per EA (NDC 00904730224), effective Jun 24, 2026.
How has the price of APRODINE TABLET changed over time?
Over the history we have for it, the NADAC for APRODINE TABLET has risen 53.8%. It has been tracked across 167 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for APRODINE TABLET?
Since Apr 19, 2023, the NADAC for APRODINE TABLET has ranged from a low of $0.0420 (Oct 23, 2024) to a high of $0.0720 (Jun 24, 2026), with a median of $0.0470 per EA.
Are there cheaper alternatives to APRODINE TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as APRODINE TABLET, but none are currently priced below it.
Who manufactures APRODINE TABLET?
APRODINE TABLET (NDC 00904730224) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification